From Name:
From Email:
To Name:
To Email:

Optional Message:


What's causing the antibiotic development stagnation?

from By Lauren Swan

Antimicrobial-resistant bacteria are appearing in headlines more often as time goes by, along with the escalating need for new antibiotics to treat these bacteria. Yet only two new antibiotic treatments have been approved and released onto the market since 2008. There are currently seven new antimicrobial drugs in the FDA pipeline, but none of them will affect the bacteria for which we need them. So where are all the new antibiotics? Why are there so few in the pipeline? It really comes down to three reasons, none of them particularly good. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063